Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization

References

• Bonneville M, O’Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. 2010;10(7):467–478. doi:10.1038/nri278120539306
   PubMed Web of Science ®Google Scholar
• Gao Y, Yang W, Pan M, et al. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med. 2003;198(3):433–442. doi:10.1084/jem.2003058412900519
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–945. doi:10.1038/nm.390926193342
   PubMed Web of Science ®Google Scholar
• Wu D, Wu P, Qiu F, Wei Q, Huang J. Human gammadelta T-cell subsets and their involvement in tumor immunity. Cell Mol Immunol. 2017;14(3):245–253. doi:10.1038/cmi.2016.5527890919
   PubMedGoogle Scholar
• Alnaggar M, Xu Y, Li J, et al. Allogenic Vgamma9Vdelta2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma. J Immunother Cancer. 2019;7(1):36. doi:10.1186/s40425-019-0501-830736852
   PubMed Web of Science ®Google Scholar
• Poggi A, Zocchi MR. Gammadelta T lymphocytes as a first line of immune defense: old and new ways of antigen recognition and implications for cancer immunotherapy. Front Immunol. 2014;5:575. doi:10.3389/fimmu.2014.0057525426121
   PubMed Web of Science ®Google Scholar
• Anitha A, Sowmya S, Kumar PTS, et al. Chitin and chitosan in selected biomedical applications. Prog Polym Sci. 2014;39(9):1644–1667. doi:10.1016/j.progpolymsci.2014.02.008
   Web of Science ®Google Scholar
• de Oliveira Pedro R, Hoffmann S, Pereira S, Goycoolea FM, Schmitt CC, Neumann MG. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. Eur J Pharm Biopharm. 2018;131:203–210. doi:10.1016/j.ejpb.2018.08.00930145220
   PubMed Web of Science ®Google Scholar
• Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 2010;62(1):3–11. doi:10.1016/j.addr.2009.09.00419800377
   PubMed Web of Science ®Google Scholar
• Shi GN, Zhang CN, Xu R, et al. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Biomaterials. 2017;113:191–202. doi:10.1016/j.biomaterials.2016.10.04727816821
   PubMed Web of Science ®Google Scholar
• Carroll EC, Jin L, Mori A, et al. The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of Type I interferons. Immunity. 2016;44(3):597–608. doi:10.1016/j.immuni.2016.02.00426944200
   PubMed Web of Science ®Google Scholar
• Castro F, Pinto ML, Silva AM, et al. Pro-inflammatory chitosan/poly(gamma-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity. Acta Biomater. 2017;63:96–109. doi:10.1016/j.actbio.2017.09.01628919508
   PubMedGoogle Scholar
• Wu Y, Sims RC, Zhou A. AFM resolves effects of ethambutol on nanomechanics and nanostructures of single dividing mycobacteria in real-time. Phys Chem Chem Phy. 2014;16:19156–19164. doi:10.1039/C4CP01317D
   PubMed Web of Science ®Google Scholar
• Wu YZ, McEwen GD, Harihar S, Baker SM, DeWald DB, Zhou AH. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study. Cancer Lett. 2010;293(1):82–91. doi:10.1016/j.canlet.2009.12.01620083343
   PubMed Web of Science ®Google Scholar
• McEwen GD, Wu Y, Tang M, et al. Subcellular spectroscopic markers, topography and nanomechanics of human lung cancer and breast cancer cells examined by combined confocal Raman microspectroscopy and atomic force microscopy. Analyst. 2013;138:787–797. doi:10.1039/C2AN36359C23187307
   PubMedGoogle Scholar
• Meraviglia S, Lo Presti E, Dieli F, Stassi G. Gammadelta T cell-based anticancer immunotherapy: progress and possibilities. Immunotherapy. 2015;7(9):949–951. doi:10.2217/imt.15.6826569071
   PubMedGoogle Scholar
• Huang X, Guo H, Wang C, et al. Detection of CD28/CD86 co-stimulatory molecules and surface properties of T and dendritic cells: an AFM study. Scanning. 2016;38(4):365–375. doi:10.1002/sca.v38.426507362
   PubMedGoogle Scholar
• Hu M, Wang J, Zhao H, Dong S, Cai J. Nanostructure and nanomechanics analysis of lymphocyte using AFM: from resting, activated to apoptosis. J Biomech. 2009;42(10):1513–1519. doi:10.1016/j.jbiomech.2009.03.05119477449
   PubMedGoogle Scholar
• Wang J, Wan Z, Liu W, et al. Atomic force microscope study of tumor cell membranes following treatment with anti-cancer drugs. Biosens Bioelectron. 2009;25(4):721–727. doi:10.1016/j.bios.2009.08.01119734031
   PubMed Web of Science ®Google Scholar
• Cui YH, Hu ZX, Gao ZX, et al. Airborne particulate matter impairs corneal epithelial cells migration via disturbing FAK/RhoA signaling pathway and cytoskeleton organization. Nanotoxicology. 2018;12(4):312–324. doi:10.1080/17435390.2018.144065129463199
   PubMed Web of Science ®Google Scholar
• Billadeau DD, Nolz JC, Gomez TS. Regulation of T-cell activation by the cytoskeleton. Nat Rev Immunol. 2007;7(2):131–143. doi:10.1038/nri202117259969
   PubMed Web of Science ®Google Scholar
• Kuhn JR, Poenie M. Dynamic polarization of the microtubule cytoskeleton during CTL-mediated killing. Immunity. 2002;16(1):111–121. doi:10.1016/S1074-7613(02)00262-511825570
   PubMed Web of Science ®Google Scholar
• Cao G, Wang Q, Li G, et al. mTOR inhibition potentiates cytotoxicity of Vgamma4 gammadelta T cells via up-regulating NKG2D and TNF-alpha. J Leukoc Biol. 2016;100(5):1181–1189. doi:10.1189/jlb.5A0116-053RR27256566
   PubMed Web of Science ®Google Scholar
• Zeng D, Lin J, He H, et al. Therapeutic effect of targeted Fas-expressing adenoviruses method combining gamma delta T cells in a mouse model of human ovarian carcinoma. Oncol Lett. 2018;15(2):2555–2561. doi:10.3892/ol.2017.759929434973
   PubMedGoogle Scholar
• Brandes M, Willimann K, Bioley G, et al. Cross-presenting human T cells induce robust CD8+ T cell responses. Proc Natl Acad Sci. 2009;106(7):2307–2312. doi:10.1073/pnas.081005910619171897
   PubMedGoogle Scholar
• Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gamma delta T Cells. Science. 2005;309(5732):264–268. doi:10.1126/science.111026715933162
   PubMed Web of Science ®Google Scholar
• Hines MR, Nichols KE. Go with the flow: perforin and CD107a in HLH. Blood. 2017;129(22):2954–2955. doi:10.1182/blood-2017-04-77319228572174
   PubMedGoogle Scholar
• Sanyakamdhorn S, Agudelo D, Tajmir-Riahi HA. Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles. Biomacromolecules. 2013;14(2):557–563. doi:10.1021/bm301857723305154
   PubMedGoogle Scholar
• Alexander AAZ, Maniar A, Cummings JS, et al. Isopentenyl pyrophosphate-activated CD56+ T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin Cancer Res. 2008;14(13):4232–4240. doi:10.1158/1078-0432.CCR-07-491218594005
   PubMedGoogle Scholar
• Li Z, Xu Q, Peng H, Cheng R, Sun Z, Ye Z. IFN-gamma enhances HOS and U2OS cell lines susceptibility to gammadelta T cell-mediated killing through the Fas/Fas ligand pathway. Int Immunopharmacol. 2011;11(4):496–503. doi:10.1016/j.intimp.2011.01.00121238618
   PubMed Web of Science ®Google Scholar
• Lafouresse F, Vasconcelos Z, Cotta-de-Almeida V, Dupre L. Actin cytoskeleton control of the comings and goings of T lymphocytes. Tissue Antigens. 2013;82(5):301–311. doi:10.1111/tan.2013.82.issue-524131017
   PubMedGoogle Scholar